The British National Formulary (BNF) documents no direct pharmacological interaction between liraglutide and fluoxetine, but the decision to combine them must always be made by your GP or prescribing clinician, who can assess your complete medical history and treatment goals
By 56 weeks of treatment, 56% of people taking Saxenda lost at least 5% of their body weight
Inhibitory kinetic interactions between hp GSTP1-1 and IAA To elucidate the mode of inhibition and determine inhibition constants, kinetic analyses were conducted in the presence of increasing concentrations of IAA (0.25, 0.5, 1, and 2 mM)
The improvement in both HS-PGA and DLQI was possibly due to combined actions of weight loss and GLP-1 receptor activation
Funding This work was supported by grants from the Chung Shan Medical University Hospital (CSH-2020-C-016)
Nitric oxide treatment attenuates muscle atrophy during hind limb suspension in mice